Rethinking the ethics of vaccination
- Funded by British Academy
- Total publications:0 publications
Grant number: COV19\200862
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$12,496.09Funder
British AcademyPrincipal Investigator
Dr. Stephen JohnResearch Location
United KingdomLead Research Institution
University of Cambridge, Department of History and Philosophy of ScienceResearch Priority Alignment
N/A
Research Category
Research to inform ethical issues
Research Subcategory
Research to inform ethical issues related to Public Health Measures
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Politicians and epidemiologists often claim that developing a Covid-19 vaccination is key to combating the pandemic. However, vaccine development and distribution raises difficult ethical questions: how certain must we be that vaccines are safe before using them in the general population? How should we choose whom to vaccinate when we can't vaccinate everyone? Should we make vaccination mandatory? As the high-profile MMR case exemplifies, these problems intersect with public vaccine hesitancy, and, therefore, public trust in science. These challenges will be even more significant in the case of a Covid-19 vaccine, which will be developed in haste, probably in short supply, and administered against a general backdrop of fear and suspicion. This project aims to use existing philosophical work on vaccination to think through the principles for ethical development and distribution of a Covid-19 vaccine, with the aim of contributing to policies which are fair, effective and trustworthy.